Valvular & structural heart disease

Interplay of aortic stenosis flow groups and mitral regurgitation aetiology in patients undergoing transcatheter aortic valve replacement

Eur Heart J Cardiovasc ImagingPublished retrospective analysis

Authors' conclusion

MR aetiology and severity influence outcomes after TAVR depending on AS flow groups.

Study context

Population
Patients undergoing transcatheter aortic valve replacement (TAVR) (2013–21) across aortic stenosis (AS) flow groups531 (20.0%) with at least moderate mitral regurgitation (MR) (MR ≥ 2+)
Participants
2,658 patients
Exposure
Impact of MR aetiology and severity on outcomes across AS flow groups in TAVR patients
  • MR2+n = 531
Outcome
Fraction of patients with MR ≥ 2+

Main finding

As reported in the abstract

cLFLG-AS

34.2%

Observational data: associations, not effects.

Further findings

OutcomeValuesHR (CI)
Mortality by MR severity · 3 yearsMR2+vs MR < 2All patients1.62 (1.38–1.90)
Mortality by MR severity · 3 yearsMR2+vs MR < 2HG-AS1.52 (1.16–1.98)
Mortality by MR severity · 3 yearsMR2+vs MR < 2pLFLG-AS1.73 (1.24–2.40)
Mortality by MR severity · 3 yearsMR2+vs MR < 2cLFLG-AS; no difference1.21 (0.93–1.56)

Mortality with MR improvement

HR (CI)
MR improvementHG-AS; lower mortality0.21 (0.10–0.43)
MR improvementcLFLG-AS; lower mortality0.48 (0.29–0.79)
OutcomeValuesEstimateP value
MR aetiology by AS subtypecLFLG-AS vFMR 83.0% · pLFLG-AS aFMR 43% · PMR 45%
MR improvement after TAVRpLFLG-AS vs HG-ASHG-AS 67.2% · pLFLG-AS 48.7%P = 0.03
Mortality with MR improvementMR improvement · pLFLG-AS; not the case1.32 (CI 0.67–2.59)

Characteristics of MR ≥ 2+ patients

Male
50.1%
Median age
83.1 years

Original publication

Interplay of aortic stenosis flow groups and mitral regurgitation aetiology in patients undergoing transcatheter aortic valve replacement. Eur Heart J Cardiovasc Imaging. Published 29 August 2025. doi:10.1093/ehjci/jeaf254

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.